MRK
NYSE
$124.40
Merck & Co Inc (MRK)
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Sector:
Healthcare
Industry:
Drug Manufacturers - General
Buy
Target: $134.04 (+7.75%)
Market Cap
$292B
P/E Ratio
26.93
Free Cash Flow Yield
4.84%
Dividend Yield
2.57%
Price Chart
Valuation
Market Cap$292B
P/E26.93
Forward P/E47.17
PEG6.13
P/S4.54
P/B6.68
Profitability
Total Revenue (TTM)$66B
Gross Profit (TTM)$50B
EBITDA$16B
Profit Margin-26%
EPS$4.59
Financial Health
Debt-to-Equity107.1%
Free Cash Flow Yield4.84%
Dividend Yield2.57%
Growth & Risk
EPS 5Y CAGR+5.37%
Revenue 5Y CAGR+10.41%
FCF 5Y CAGR+5.49%
Dividends 5Y CAGR+11.02%
Beta (5Y)0.29
Sharpe Ratio1.63